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Introduction 
As a result of the Expanded Programme on Immunisation (EPn of WHO 
and UNICEF, 80% of the world's children are now immunised against six 
leading childhood diseases (measles, poliomyelites, diphtheria, 
tetanus, pertussis and tuberculosis), as announced by the Secretary 
General of the United Nations in October 1991. This opposes the figures 
published in 1974, where 50% of children aged under 1 year were 
immunised, when EPI was established (Gillen, 1991). 
Obviously, this figure also includes the Maltese child population. In fact 
the Department of Health, through its international connections with 
WHO, is today fully committed to the strategy of Health for All by the 
Year 2000 of which immunisation forms an integral part. 
The impact immunisation has had on the epidemiology of disease in 
Malta is emphasised by records available at the Health Information 
Systems Unit (HISU) at St Luke's Hospital. As shown by Figures I, 2 and' 
3: 
i) the last notified cases of poliomyelites and diphtheria date back 
to 1964 and 1969 respectively; 
i i) notified deaths from these two diseases date back even further: 
1952 for poliomyelites and 1962 for diphtheria; 
i i i) measles and pertussis tend to occur in epidemics bu t in the last four 
years notified cases have been very low. 
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For an immunisation programme to have s.uch an impact on disease 
epidemiology, it must be based on an efficient Immunisation Schedule. 
Below is the immunisation schedule being followed in the Maltese 
Islands at the time of this study: 
Vaccine 
a: 
DTP dose 1 + Polio 
DTP dose 1 + Polio 
DTP dose 1 + Polio 
or 
DTP dose 1 + Polio 
DTP dose 1 + Polio 
DTP dose 1 + Polio 
b: MMR 
DT + Polio booster doses . 
MMR to - unvaccinated children 
- those who have had measles 
vaccine only 
Rubella in females 
BCG 
Tetanus + Polio 
DTP: 
DT: 
MMR: 
Diphtheria/Tetanus/Pertussis Vaccine 
Diphtheria/Tetanus Vaccine 
Measles /Mumps /Rubella Vaccine 
Bacillus Calmette-Guerin Vaccine 
Age 
3 months 
4 months 
5 months 
3 months 
4.5-5 months 
8-10 months 
15 months 
4 years 
11 years 
12-14 years 
16 years 
BCG: 
a: 
b: 
Since August 1990, the accelerated schedule for DTP vaccination 
was adopted due to a whooping cough epidemic. Before this 
date, DTP vaccination followed the same schedule as DT 
vaccination. The normal schedule was resumed in January 1992. 
MMR vaccine was introduced instead of single measles vaccine in 
July 1990. An addition to the above schedule is the introduction 
of a booster dose at 12 years of age. 
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Immunisation in Malta is obligatory against diphtheria, tetanus and 
polio but only recommended against pertussis, measles in MMR form and 
BCG although parents are greatly encouraged to perform all types of 
immunisations. 
The Maltese parenthood has two options for immunisation of a child: 
1) attendance at a G.P. or Pediatrician of choice; 
2) attendance at Free Immunisation Services (FIS) clinics which the 
Department of Health offers at Health Centres spread around the 
island. 
As part of this project, the latter service has not only been closely 
followed and examined but has been utilised to perform the main studies 
of this project which included an aSsessment of -
i) the attitude of the Maltese parenthood to immunisation and an 
estimation of their awareness on the necessity and importance of 
immunisation; 
i i) the incidence of reactions, if any, followed vaccination. 
A further aim of this project has been to establish a role for the 
pharmacist in Malta's immunisation programme. 
Methodology 
Study 1 
Parental Attitudes to Childhood Immunisation 
A survey was conducted among 164 families randomly attending 
immunisation clinics for routine immunisation of one or more children at 
six Healt~ Centres providing FIS over a 4 month period. The parents 
were interviewed in Maltese on the basis of a set of questions designed not 
only to estimate their attitudes towards immunisation but also their 
expectations on the immunisation programme. 
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Study 2 
Surveillance of Reactions to Vaccines 
Following vaccination with DTP (Diphtheria/Tetanus/Pertussis)/DT 
(Diphtheria/Tetanus) and MMR (Measles/Mumps/Rubella) vaccines, 93 
children (58 females, 35 males) and 85 children (40 females, 45 males) 
respectively were monitored to investigate the development, if any, of 
reactions. The study was performed by telephone after obtaining the 
parents' consent. In both cases the parents were contacted on two 
occasions: 
DTP /DT Group: 24 hours and 48 hours after vaccine administration 
MMR Group: on the eighth day and at the end of the third week 
following vaccine administration. 
Study 3 
The Role of the Pharmacist in Immunisation 
A questionnaire was distributed by hand and by post to 140 community 
pharmacists (70 answered) to assess whether a pharmacist has a role in 
immunisation and whether he/she is in a position to play such a role. 
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Table 2: Record Keeping By Parents 
THIS CHILD SIBLINGS 
--_._-
FORM OF RECORD % AVAILABLE FOR % 
FIS card 9U all siblings 92.8 
Private Doctor some siblings 3.6 
card 8.9 
none of the 
siblings 3.6 
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Fig. 5: Delays in Vaooination Days 
Delayed On One or More 
Occasions 
59.8% 
Question Not. 
Applicahlc 
6.L';', 
Does Not 
Remember 
0.6% 
Never Delayed 
33.5% 
Table 3: Reasons for Vaovination Delays 
REASON % 
illness of the child 70.4 
the mother forgot/confused 
the date 11.2 
the mother cannot always 
come on the appointed date 3.1 
the mother was pregnant 3.1 
the mother waits until 
someone can accompany her 2.0 
started vaccination late 
and kept delaying 2.0 
delayed not to disrupt 2.0 
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Table 4: Preferred Form of Information 
FORM % 
-
leatlets 79.6 
T.V. commercials 76.4 
videos 74.5 
picture booklets 29.3 
oh arts 28.7 
radio broadcasls 22.3 
lectures 6.4 
health visi ling 2.5 
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Table 5: Receipt, of Health Education on 
Immunisation b.y Parents 
YES NO 
N= 74 %=45,1 N=90 %=54,9 
SOURCES OF KNOWLEDGE % OTHER INFO SOURCES 
anlenalal courses 6" 'l ,-"" laid la vaccinale after 
literature 47,3 t.he child was born 
dodor's explanations informed on lhe firsl 
during check-ups 9.5 posL--nalal visil 
t.he mother herself is rela lives 
a heallh professional 5.4 receipt of Heallh 
information given by Department nole 
other health carers 4.1 friends & neighbours 
the media 1.4 jusl knew about. 
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Study 2 
Out of 93 children aged 3 months-6years receiving DTP and DT vaccine, 
the results were as follows: 
SYMPTOMLESS ONE OR MORE SYMPTOMS 
18.3% 81.7% 
(DTP: 55.5%; DT: 44.7%) 
Fig. 7: Nillure of Symptoms in 78 Children 
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Out of 85 children aged 15 months-12 years receiving MMR vaccine, the 
following results were obtained: 
SYMPTOMLESS ONE OR MORE SYMPTOMS 
50.6% 49.4% 
Fig. 8: Nature of S'ympt0J118 in 42 Children 
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Study 3 
Other results of Study 3 include 
a) out of those pharmacists who were elicited help on immunisation 
problems (n=60), 86.7% were able to help and advice although the 
majority with difficulty; 
b) 98.6% (n=69) of the total pharmacists showed an interest in having 
leaflets for distribution in the pharmacy and 95.7% (n=67) thought 
that such leaflets would attract a mother's attention; 
c) the majority (51.4%) described pertussis vaccine as being 
mciderately effective and out of these 80% (n=50) would recommend 
it to parents; 
d) 75.7% (n=53) considered adverse reactions to vaccines to be rare; 
e) with regards to contraindications to immunisation,. 100% of 
pharmacists included one or more considered to be false 
contraindications (DHSS, 1990); 
f) illness of the child at the time of vaccination was described as 
being the main cause of delayed vaccination (84.3%). This 
compares with the main reason for delays in immunisation stated 
by parents (Table 3); 
g) 90% (n=63) of pharmacists expressed an interest in further 
knowledge and education on immunisation. 
Discussion 
Many parents still view immunisation as a potential hazard that shoud 
be avoided if some excuse should be found (Klein et aI, 1989). In fact, 
many parents were found to be very apprehensive about' immunising a 
child and this more often than not stemmed from poor knowledge and 
understanding on the parents' behalf regarding both 
1) the disease concerned; 
2) the process of immunisation itself. 
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This is also the reason why some parents fail to immunise their children 
against whooping cough. In recent years, there has been a lot of 
controversy about possible neurological damage thought to be caused by 
DTP vaccine and this has confused parents and health professionals 
alike (Nicoll, 1985). This is emphasised by the fact that the majority of 
parents (90%) questioned on the reason for refusing DTP vaccine stated 
invalid reasons: validity or invalidity of reasons was based on the 
United Kingdom's Department of Health and Social Security guidelines 
for 1990. Also, out of those mothers who had always delayed vaccination 
on one or more occasions, the majority gave invalid reasons for the delay. 
Further lack of knowledge was emphasised by the high percentage of 
mothers who-
i) were unable to mention any of the vaccine components being 
administered to their child; 
ii) never received any form of appropriate health education regarding 
immunisation. 
Reactions following the administration of vaccines was found to be 
another reason why parents tend to be so apprehensive regarding 
immunisation. Surveillance of reactions following DTP IDT vaccination 
revealed the occurrence of minor reactions only. No serious symptoms 
were reported i.e. no case of collapse, convulsions or encephalopathy 
occurred. Local reactions were found to be the most common (76.9%). The 
figure obtained was somewhat higher than that observed by eody et al 
(64%) and Verschoor et al (66.2%) but a higher incidence of 85% was 
reported by Long et al (1990). The fact that only a small percentage of 
children developed fever might be attributable to the tendency of 
mothers (86%) to administer paracetamol prophylactically. Such a drug 
can influence temperature, pain and associated behavioural reactions. In 
fact, Verschoor et al (1991) reported 78.2% cases involving fever with 
only 11 % of the children enrolled having received some drug. Therefore, 
on comp,aring with other studies, variations were observed in the 
incidence rates reported. Interpretation of data may be influenced by the 
composition of the vaccine used, the vaccination schedule and ages, 
definitions of possible reactions and the manner and frequency of 
observations (Verschoor et aI, 1991). Besides, in this project, reactions 
were reported by the parents themselves who might have exaggerated or 
underestimated the severity of any symptoms. 
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Surveillance to MMR vaccination revealed rash, followed by fever, to be 
the most frequent symptom which developed a week after MMR vaccine 
.administration. These symptoms were alsQ reported as being common by 
Miller et al (1989). In their study, MMR and Measles vaccines were 
compared and incidence of both symptoms found to be comparable. 
Therefore, Miller et al (1989) state that the increase in symptom 
frequency about a week after MMR vaccination can be attributed to 
viremia from the measles component. In this project it was not possible to 
use a measles vaccine group as a control because since the introduction of 
MMR vaccine in July 1991, the percentage of children being immunised 
against measles alone is negligible. When faced with the choice, the 
majority of parents prefer the triple vaccine. Results of surveillance 
following MMR vaccine also vary between studies. In this project, the 
majority of children vaccinated proved symptomless (50.6%). Robertson 
et al (1988) described only about 10% of symptomless children while 
Peltola and Heinonen (1986), in a placebo-controlled twin study, found 
the actual incidence of reactions to be very low (0.5-4%) with some 
symp~oms having a higher incidence in the palcebo group .• The results 
obtained in the Maltese children may have been influenced by the 
following factors: 
1) the parents themselves have reported the symptoms and they may 
have overestimated any symptom; 
2) children in the age group studied suffer from coincidental illnesses. 
In this project the subject of immunisation has been dealt with from 
various angles. Therefore one can finally look into the role of the 
pharmacist. Vaccines are pharmaceutical products and the pharmacist 
must be duly informed about the different vaccines available, the 
necessary storage conditions and the frequency of any reactions following 
immunisation. However, the role of the pharmacist should not stop at 
this point: in fact, tije majority of pharmacists questioned did not define 
the role of the pharmacist as that of procurement and storage of vaccines 
but mostly as an advisor and health educator for parents. The community 
pharmacist especially is in an ideal position for providing health 
education being in close contact with mothers of young children. 
However, the majority of parents questioned have never elicited 
pharmacists' help regarding immunisation and even though some 
pharmacists have been able to help on demand, the majority did so with 
difficulty since they did not consider themselves sufficiently informed. 
This can be remedied if the health authorities were to keep pharmacists 
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continuously informed about the Maltese Immunisation Programme, the 
current schedule and any changes brought about. Charts and leaflets 
should be available for distribution in pharmacies; these would not only 
act as a source of information for the young mother but would also help to 
involve the pharmacist in the immunisation scheme. 
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